Price Alert

Globus Medical Inc. (GMED)

NYSE: GMED · Real-Time Price · USD

59.98

-2.81 (-4.48%)

At close: Aug 14, 2025, 3:59 PM

60.02

0.07%

After-hours: Aug 14, 2025, 06:07 PM EDT

-4.48% (1D)

Bid	60.02
Market Cap	8.1B
Revenue (ttm)	2.51B
Net Income (ttm)	185.56M
EPS (ttm)	2.58
PE Ratio (ttm)	23.25
Forward PE	16.25
Analyst	Buy

Ask	63.36
Volume	1,318,830
Avg. Volume (20D)	1,782,598.1
Open	62.31
Previous Close	62.79
Day's Range	59.85 - 62.43
52-Week Range	51.79 - 94.93
Beta	1.20

About GMED

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol GMED

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for GMED stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Globus Medical has released their quartely earnings on Aug 7, 2025:

Revenue of $745.34M exceeds estimates by $3.03M, with 18.37% YoY growth.

EPS of 0.86 exceeds estimates by 0.10, with 14.67% YoY growth.

Next Earnings Release

Globus Medical Inc. is scheduled to release its earnings on Nov 4, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

+8.47%

Globus Medical shares are trading higher after the... Unlock content with Pro Subscription

1 week ago

+2.35%

Globus Medical shares are trading higher after the company reported better-than-expected Q2 financial results.

News

2 days ago · zacks.com

Globus Medical Stock Up on Q2 Earnings & Revenue Beat, Margins Expand

GMED posts strong Q2 with earnings and revenues, boosted by the Nevro acquisition and expanded margins.

1 week ago · seekingalpha.com

Globus Medical, Inc. (GMED) Q2 2025 Earnings Call Transcript

Globus Medical, Inc. (NYSE:GMED ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Brian J. Kearns - Senior Vice President of Business Development & Investor Relations D...

1 week ago · zacks.com

Globus Medical (GMED) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Globus Medical (GMED) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall S...

1 week ago · zacks.com

Globus Medical (GMED) Beats Q2 Earnings and Revenue Estimates

Globus Medical (GMED) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.75 per share a year ago.

1 week ago · fool.com

Globus Medical (GMED) Q2 Revenue Up 18%

1 week ago · zacks.com

Stay Ahead of the Game With Globus Medical (GMED) Q2 Earnings: Wall Street's Insights on Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Globus Medical (GMED), delve into some of its key metrics to gain a deeper insight into the company's potential performance for ...

2 weeks ago · zacks.com

Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago · zacks.com

GMED Unveils Next-Gen Oscillating System DuraPro: Stock to Gain?

Globus Medical debuts DuraPro with Excelsius integration, boosting its Power Portfolio.

1 month ago · seekingalpha.com

Globus Medical: Obtaining My Backing Again

Globus Medical shares have reset after a soft Q1 and Nevro acquisition, making valuations more attractive despite near-term dilution. The company's strong growth, driven by NuVasive integration and pr...

2 months ago · accessnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED

NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company") (NYSE:GMED). Such investors are a...

Load More News